Endpoints in stem cell trials in ischemic heart failure

Despite multimodal regimens and diverse treatment options alleviating disease symptoms, morbidity and mortality associated with advanced ischemic heart failure remain high. Recently, technological innovation has led to the development of regenerative therapeutic interventions aimed at halting or rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Banovic, Marko, Loncar, Zlatibor, Behfar, Atta, Vanderheyden, Marc, Beleslin, Branko, Zeiher, Andreas, Metra, Marco, Terzic, Andre, Bartunek, Jozef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552990/
https://www.ncbi.nlm.nih.gov/pubmed/26319401
http://dx.doi.org/10.1186/s13287-015-0143-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552990/
https://www.ncbi.nlm.nih.gov/pubmed/26319401
http://dx.doi.org/10.1186/s13287-015-0143-9

Ejemplares similares